Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer.
Ito M, Oji Y, Adachi M, Imanishi R, Alzaaqi S, Hiwasa T, Oshima Y, Yajima S, Suzuki T, Nanami T, Sumazaki M, Shiratori F, Funahashi K, Sugiayama H, Shimada H. Ito M, et al. Among authors: sumazaki m. Mol Clin Oncol. 2022 Mar;16(3):74. doi: 10.3892/mco.2022.2507. Epub 2022 Feb 1. Mol Clin Oncol. 2022. PMID: 35251625 Free PMC article.
Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer.
Ito M, Hiwasa T, Oshima Y, Yajima S, Suzuki T, Nanami T, Sumazaki M, Shiratori F, Funahashi K, Li SY, Iwadate Y, Yamagata H, Jambaljav B, Takemoto M, Yokote K, Takizawa H, Shimada H. Ito M, et al. Among authors: sumazaki m. Front Oncol. 2021 Aug 24;11:708039. doi: 10.3389/fonc.2021.708039. eCollection 2021. Front Oncol. 2021. PMID: 34504788 Free PMC article.
Comparison between a new assay system, Elecsys® Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study.
Suzuki T, Oshima Y, Shiratori F, Nanami T, Yajima S, Sumazaki M, Ushigome M, Sugita H, Eberl M, Ogata H, Hayashida T, Nakamura S, Nakagawa T, Shimada H. Suzuki T, et al. Among authors: sumazaki m. Mol Clin Oncol. 2022 Jun 22;17(2):130. doi: 10.3892/mco.2022.2563. eCollection 2022 Aug. Mol Clin Oncol. 2022. PMID: 35832468 Free PMC article.
Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
Li SY, Yoshida Y, Kobayashi E, Adachi A, Hirono S, Matsutani T, Mine S, Machida T, Ohno M, Nishi E, Maezawa Y, Takemoto M, Yokote K, Kitamura K, Sumazaki M, Ito M, Shimada H, Takizawa H, Kashiwado K, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H, Zhang XM, Wang H, Goto K, Iwadate Y, Hiwasa T. Li SY, et al. Among authors: sumazaki m. Int J Mol Med. 2020 Oct;46(4):1274-1288. doi: 10.3892/ijmm.2020.4690. Epub 2020 Jul 29. Int J Mol Med. 2020. PMID: 32945427 Free PMC article.
Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
Sumazaki M, Shimada H, Ito M, Shiratori F, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Iwadate Y, Mine S, Machida T, Kamitsukasa I, Mori M, Sugimoto K, Uzawa A, Kuwabara S, Kobayashi Y, Ohno M, Nishi E, Maezawa Y, Takemoto M, Yokote K, Takizawa H, Kashiwado K, Shin H, Kishimoto T, Matsushita K, Kobayashi S, Nakamura R, Shinmen N, Kuroda H, Zhang XM, Wang H, Goto KI, Hiwasa T. Sumazaki M, et al. Cancer Sci. 2020 Dec;111(12):4453-4464. doi: 10.1111/cas.14652. Epub 2020 Oct 4. Cancer Sci. 2020. PMID: 32939876 Free PMC article.
17 results